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ABSTRACT
Current advances within medical technology show great potential from a global health
perspective. Inexpensive, effective solutions to common problems within diagnostics, medical
procedures and access to medical information are emerging within almost all fields of
medicine. The innovations can benefit health care both in resource-limited and in resource-
rich settings. However, there is a big gap between the proof-of-concept stage and imple-
mentation. This article will give examples of promising solutions, with special focus on mobile
image- and sensor-based diagnostics. We also discuss how technology and frugal innovations
could be made sustainable and widely available. Finally, a list of critical factors for success is
presented, based on both our own experiences and the literature.
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Frugal mobile health innovations
Advances within the fields of connected and mobile
health (mHealth) have recently generated a series of
promising medical technologies that address global
health-related challenges. Innovations include inex-
pensive, effective solutions to common problems
within diagnostics, medical procedures and access to
medical information often with minimal use of
resources [1]. These so-called frugal innovations
have often been sparked by global health initiatives,
donators and non-governmental organizations
(NGOs) and typically can benefit health care both
in resource-limited and in higher-income settings.
Inexpensive, mass-produced components from the
mobile and microelectronics industry, 3D printing,
miniaturization, artificial intelligence and lab-on
-a-chip techniques allow for unexpected, low-cost and
point-of-care solutions. Task-shifting, where for exam-
ple diagnostic devices and tests can be used by less-
skilled persons or patients themselves, can improve
access to diagnostics in a global perspective. The novel
mobile solutions enable health care to be provided
wherever people are, not only in health-care facilities.
However, most of the innovations still remain at a
proof-of-concept stage or are limited to pilot studies,
the so-called ‘pilotitis’ syndrome; see Sundin et al. [2]
for an analysis of a number of failure modes for
mHealth projects. Examples include the Ghana-based
HealthKeepers, anmHealth organization that failed due
to its inability to attract external funding, and the
Zambia-based Mwana, which failed due to underesti-
mation of the computing power required by its servers
when scaling. This rate of failures is so alarming that
some countries such as Uganda refuse to engage in any
new mHealth projects. There is also the question
whether more of already existing medical technologies
could be made cheaper and accessible in resource-
limited settings and whether the advances in mobile
technologies really have been fully utilized.
Unleash the global potential of digital medicine
and connected health
In this article, we bring up aspects on how the huge
advances in connectivity, access to information and
computational capacity could have an even bigger
impact on health care and how the potential could
be unleashed within a global health setting. The use
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of mobile technologies could improve the quality of
services and access to health care, particularly in
underserved rural areas [3].
Connected health solutions, electronic medical
records, geographical positioning systems, sensors
and cloud computing can contribute to more efficient
health care and are part of the digitalization of medi-
cine. Future perspectives include an increasing use of
artificial intelligence (AI) and machine learning (ML)
in computer-assisted clinical decision-support systems
(CDSS). AI will provide support and intelligence aug-
mentation rather than replace the human expert. AI
and CDSS will assist experts to perform better and
through machine learning make use of previously col-
lected and shared information. Surveillance and epide-
miology will greatly benefit from improved
connectivity and processing of already existing big
data, connecting distributed data sources and location
information. Mobile connectivity also provides effi-
cient channels for distribution of information, remin-
ders and follow-up to monitor the effects of treatment.
Image-based diagnostics
A specific field of mobile medical technologies relates to
the use of imaging. A picture is worth a thousand words,
which clearly also holds true within mobile health. A
large number of mobile health solutions have been pre-
sented within this field, including applications for emer-
gency medicine, surgery, otolaryngology,
ophthalmology, dermatology, radiology, pathology and
general medicine [4]. Specific applications such as burn
injury consultation [5], oral cancer diagnostics [6], diag-
nosis of middle-ear infections [7], refraction tests and
cataract assessment (Eyenetra, Somerville, MA), skin
cancer detection (SkinVision, SkinVision BV,
Amsterdam, Netherlands and MoleScope, MetaOptima,
Vancouver, BC) and parasite and cancer microscopy-
based diagnosis [8–10] to name a few. A series of por-
table ultrasound systems are available that can display the
image on portable devices, providing rugged low-cost
systems that do not compromise the image quality
(VScan, GE Healthcare, Chicago, IL, and Clarius,
Burnaby BC, Canada). Recently, a smartphone-based
platform suitable for low-cost luminescence-based point-
of-care (POC) diagnostics was developed at the
University of British Columbia (UBC) using nanoparti-
cles [11]. Nanoparticles that exhibit bright luminescence
can be designed to interact with biological systems
through control of their surface chemistry and spectro-
scopy, allowing visualization of biomarkers and thus
providing new opportunities for developing diagnostic
methods. Also simpler solutions, like taking photos of
patient findings, paper documents, logbooks and x-ray
films with a smartphone at the point-of-care and sending
these through common messaging platforms (e.g. MMS,
Whatsapp, Messenger etc.) for consultation, could be
considered as part of image-based diagnostics [12,13].
Sensor-based diagnostics
Also, othermobile light-based sensors like those included
in pulse-oximeters or in near-infrared spectroscopy are
closely related to the imaging applications. The Phone
OximeterTM developed at UBC [14], approved as a Class
II Medical device by Health Canada (Health Canada
Medical Device Licence # 94,684) and commercialized
(LionsGate Technologies, Kenek O2, Vancouver,
Canada; http://www.lgtmedical.com), provides medical-
grade oxygen saturation and heart-rate measurements at
a fraction of the cost of standardmedical oximeters. Such
a device enables further versatility of medical mobile
diagnostics particularly when coupled with predictors of
risks based on predictive analytics. This is the case with
the PIERS on theMove application [15,16] for risk assess-
ment in pre-eclampsia that is currently being tested on
thousands of pregnant women in Mozambique and
Pakistan as part of a large initiative funded by the Bill &
Melinda Gates Foundation (https://pre-empt.cfri.ca, last
visited 10 November 2016). More recently, a portable
smartphone-connected near-infrared spectroscopy
(NIRS) device has been proposed [17] that will allow for
low-cost monitoring of brain, muscle and splanchnic
hemodynamics. It is also now possible to monitor and
collect a number of vital signs using a smartphone with
accuracy comparable to more expensive medical devices,
e.g. ECG (AliveCor, San Francisco, CA, uber Diagnostics
Vijayanagar, India), blood pressure (AliveCor, LionsGate
Technologies), temperature (LionsGate Technologies),
while EEG systems are being developed, see e.g. DeLone
and McLean [18].
How to achieve sustainability and scalability?
Given all the promise of mobile medical technologies,
there is a clear discrepancy between the number of
presented and implemented innovations. There are
obvious challenges in making technology and frugal
innovations sustainable and widely available.
Financing and raising awareness are essential parts of
the process and needed to bring safe and effective
solutions to the market more quickly. Currently orga-
nizations such as WHO, Foundation for Innovative
New Diagnostics (FIND) and Program for
Appropriate Technology in Health (PATH) can pro-
vide support, but sustainability requires financial plan-
ning with a sound value proposition as the basis for a
sustainable business, effective partnerships, local pro-
cesses and policy-making to also be successful.
Simplifying the process of designing and testing
novel technologies is important, since the field is
rapidly advancing and regulatory hurdles can be a
challenge for both software and hardware companies.
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Eckman et al. propose a conceptual framework they
call design thinking that engages key stakeholders right
at the start of any mHealth project [19]. An efficient
and early collaboration between academia, industry,
non-governmental organizations and governments is
needed for success. Micro-financing instruments can
support the distribution of new products and through
the whole process universities play a key role by pro-
viding scientific evaluation of novel technologies.
Critical factors for success
Based on the literature [4,11,18,20–23] and our own
experiences we have identified the following factors
as critical in creating sustainable and scalable solu-
tions within the field of mobile and connected health:
(1) Align the new solution with a country’s existing
infrastructure and health strategies as well as eco-
nomics of health care within the government.
Development and scaling of information and
communication technologies (ICT) are largely
driven by communication and commerce needs
in general. To facilitate the improvement of
mobile infrastructure in resource-limited settings
mobile health solutions should be considered in a
broader context and coupled with similar solu-
tions for education, agriculture and small
businesses.
(2) Identify the real needs, understand the local set-
tings, e.g. existing health care, mobile infrastruc-
ture language requirements, cultural practices,
understand what motivates the end-user and
what contributes to user satisfaction. Engage the
community from the beginning and monitor the
perceived usefulness closely.
(3) Use agile product development, i.e. start the
implementation and field tests as early as possible
in the process. Get feedback from the end-users
through rigorous usability studies and the per-
ceived ease of use. Correct mistakes in design
and usability early, perform rapid iterations of
the solution and then redeploy the new version.
This approach has proven highly effective as com-
pared to traditional approaches where implemen-
tation happens late in the project.
(4) Involve all stakeholders, including health min-
istry and telecommunications agencies, network
operators, donors and end-users right from the
start of the project. Describe benefits to both
end-users and business partnerships, under-
stand all partners’ success metrics. All stake-
holders must be presented with a compelling
value proposition to ensure sustainability.
(5) Take scalability factors into consideration from
the start. A business model is needed to ensure
scaling, it cannot rely on short-term funding. A
financially viable business is the only way to
ensure perennity.
(6) Financing of projects is typically a problem and
seedmoney often comes from private philanthro-
pists and donors. It should rather be main-
streamed and include industry, telecom
companies, pharmaceutical companies and
NGOs.
(7) Promote the use of standards and integration
with the local health information-management
systems. Join global data and application repo-
sitories, promote joint collections of data and
images. Within image-based diagnostics, access
to large annotated image databases is instru-
mental both in the development of new algo-
rithms and in validation of existing ones.
(8) Evaluate feasibility and monitor the impact
and cost efficiency of a new method, taking
into account the local financial (e.g. different
level of subsidy) and technical resources (e.g.
mobile network coverage). Currently only a
very small proportion of mobile health solu-
tions are evaluated. There needs to be invest-
ment in the evaluation, both financial and
human resources. Scale-up should be preceded
by efficacy and effectiveness trials so that it is
founded on an appropriate evidence base.
Conclusions
Recent innovations within mobile and connected health
show great promise for a number of global health-
related diagnostic purposes. To implement, scale and
sustain these innovations and solutions, a number of
important factors need to be taken into account. Given
the challenges, the authors are still convinced that if the
above-mentioned critical steps are taken, a substantial
number of mobile health innovations will move into
clinical practice and wide use during the near future.
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Paper context
The extensive spread of mobile phones and mobile wireless
networks globally has led to a series of innovations within
health care that take advantage of the novel technologies and
the connectivity. These innovations often enable low-cost
solutions to medical diagnostics and improved access to
information and decision-support at the point-of-care. The
article gives a brief overview of recent mobile diagnostic
technologies, summarizes challenges and lists a series of cri-
tical factors for a successful implementation and scale-up.
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